Type | Intravascular Robotics |
---|---|
Nasdaq: HNSN | |
Industry | Medical Appliances & Equipment |
Founded | 2002 |
Headquarters | , U.S. |
Key people | Cary Vance (CEO) |
Products | Sensei Robotic System and Magellan Robotic System |
Website | www |
Hansen Medical, Inc, headquartered in Mountain View, California, designs and manufactures medical robotics for positioning and control of catheter-based technologies that was founded in 2002 by Frederic Moll, M.D. to develop tools that manipulate catheters by combining robotic technology and computerized movement.
In 2005, Hansen bought EndoVia Medical Inc., a medical robotics company. [1]
Later that year, Hansen Medical and Intuitive Surgical, another company founded by Moll, entered into a cross-licensing agreement that included Hansen's portfolio of 50 issued and pending patents and patent applications and Intuitive's 250 issued patents related to minimally invasive instruments and surgical robotics. [2] The agreement gave Intuitive Surgical an equity stake in Hansen and royalties on the future sales of Hansen Medical products. The full financial terms of the agreement were not made public. [3]
Hansen Medical went public in 2006, raising $75 million in its initial public offering with two catheter systems under FDA review. The shares represented about 30% of the company. [4] [5] [6]
In July 2016 it was acquired by Auris Surgical Robotics, and it was said to be a $80 million merger. [7] [8]
Qualcomm is an American multinational corporation headquartered in San Diego, California, and incorporated in Delaware. It creates semiconductors, software, and services related to wireless technology. It owns patents critical to the 5G, 4G, CDMA2000, TD-SCDMA and WCDMA mobile communications standards.
A royalty payment is a payment made by one party to another that owns a particular asset, for the right to ongoing use of that asset. Royalties are typically agreed upon as a percentage of gross or net revenues derived from the use of an asset or a fixed price per unit sold of an item of such, but there are also other modes and metrics of compensation. A royalty interest is the right to collect a stream of future royalty payments.
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Boston Scientific Corporation ("BSC"), incorporated in Delaware, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator (ICD) which they call the EMBLEM subcutaneous implantable defibrillator (S-ICD).
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the NASDAQ-100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.
Henry Arnold Klyce, Jr. is an American serial entrepreneur who has founded, or co-founded, four successful medical device companies.
The Da Vinci Surgical System is a robotic surgical system that uses a minimally invasive surgical approach. The system is manufactured by the company Intuitive Surgical. The system is used for prostatectomies, and increasingly for cardiac valve repair, and for renal and gynecologic surgical procedures.
Dr. Thomas J. "Tom" Fogarty is an American surgeon and medical device inventor. He is best known for the invention of the embolectomy catheter, which revolutionized the treatment of blood clots (embolus).
The Sensei X robotic catheter is a medical robot designed to enhance a physician’s ability to perform complex operations using a small flexible tube called a catheter. As open surgical procedures that require large incisions have given way to minimally invasive surgeries in which the surgeon gains access to the target organs through small incisions using specialized surgical tools. One important tool used in many of these procedures is a catheter used to deliver many of things a surgeon needs to do his work, to impact target tissue and deliver a variety of medicines or disinfecting agents to treat disease or infection.
Oxford University Innovation Limited (OUI) is a British technology transfer and consultancy company created to manage the research and development (R&D) of University spin-offs. OUI is a wholly owned subsidiary of the University of Oxford, and is located on Botley Road, Oxford, England. OUI was previously known as Isis Innovation (1988–2016) and Oxford University Research and Development Ltd (1987–1988).
Swedish Hospital is a 312-bed nonprofit teaching hospital located on the north side of Chicago, Illinois. The hospital offers over 50 medical specialties, including neurosurgery for the spine and brain, integrative cancer care, heart services, women's health services, childbirth and emergency services. The hospital has more than 600 physicians and 2,500 employees. The hospital is accredited by the American Osteopathic Association's Healthcare Facilities Accreditation Program.
The ZEUS Robotic Surgical System (ZRSS) was a medical robot designed to assist in surgery, originally produced by the American robotics company Computer Motion. Its predecessor, AESOP, was cleared by the Food and Drug Administration in 1994 to assist surgeons in minimally invasive surgery. The ZRSS itself was cleared by the FDA seven years later, in 2001. ZEUS had three robotic arms, which were remotely controlled by the surgeon. The first arm, AESOP, was a voice-activated endoscope, allowing the surgeon to see inside the patient's body. The other two robotic arms mimicked the surgeon's movements to make precise incisions and extractions. ZEUS was discontinued in 2003, following the merger of Computer Motion with its rival Intuitive Surgical; the merged company instead developed the Da Vinci Surgical System.
T3 Technion Technology Transfer is the technology transfer unit of the Technion – Israel Institute of Technology in Israel. The unit operates under the auspices of the Technion Research & Development Foundation.
Dr. Frederic Moll is a medical device developer and entrepreneur, specializing in the field of medical robotics.
Radius Ventures is a venture capital firm located in New York that invests in expansion-stage health and life sciences companies. Founded in 1997 by Jordan S. Davis and Daniel C. Lubin, Radius has raised in excess of $200 million in three funds and has invested in over 40 companies since inception. Radius invests in leading-edge, growth equity and expansion-stage health and life sciences companies.
MAKO Surgical Corp. was a publicly traded medical device company based in Florida. On September 25, 2013, the Board of Directors of Mako Surgical accepted a deal to be acquired by Stryker for $1.65B. The deal closed in December 2013.
Bertin Nahum is a French-Beninese entrepreneur in surgical robotics. He is the CEO and co-founder of Quantum Surgical based in Montpellier, France. He previously founded in 2002 Medtech S.A; specializing in the design, development and marketing of surgical assistance robots that was sold to Zimmer Biomet in 2016.
Catherine Jane Mohr is a medical researcher from New Zealand, residing in the United States, who specializes in developing telemanipulator robotics for making surgery less invasive, and therefore providing faster recovery for patients. She had also designed fuel cells for land vehicles and high-altitude airplanes and studied sustainable architecture. Mohr is on the faculty of Stanford Medical School and is currently President of the Intuitive Foundation, the corporate foundation of Intuitive Surgical.
ForSight Robotics is an Israeli surgical robotics company. It has developed a surgical robotics platform, ORYOM, to treat widespread eye diseases.